---
title: "AGARWAL AKRATI — Ownership Dossier"
canonical: https://whiteintel.dev/entity/cdc816d6-d496-5966-8a54-3bf1550bd5ff
json: https://whiteintel.dev/api/public/dossier/cdc816d6-d496-5966-8a54-3bf1550bd5ff
identifier: sec:0001973306
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AGARWAL AKRATI

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001973306`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/cdc816d6-d496-5966-8a54-3bf1550bd5ff  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/cdc816d6-d496-5966-8a54-3bf1550bd5ff  

## Ownership & control

### Holdings / subsidiaries

- **BioXcel Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/4d4ce477-16ed-5409-88a2-aa48a5c7bb5d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AGARWAL AKRATI**. Human view: https://whiteintel.dev/entity/cdc816d6-d496-5966-8a54-3bf1550bd5ff · Structured JSON: https://whiteintel.dev/api/public/dossier/cdc816d6-d496-5966-8a54-3bf1550bd5ff._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._